Kaye Scholer Obtains Dismissal of Qui Tam Suit Against Novartis
Kaye Scholer has obtained a dismissal with prejudice on behalf of Novartis Pharmaceuticals Corporation and Novartis Corporation of a qui tam suit brought in the United States District Court for the District of Massachusetts. The suit, which was brought by multiple relators under the False Claims Act, alleged off label and kickback claims in connection with the asthma drug, Xolair®.
Partner Michael Rogoff led the litigation team, which included Counsel Debra Schreck and Associate Ari Fontecchio.
» Download the file below to read the decision.